C92.01

HCC Category Mapping

What This Code Means

An acute blood cancer of myeloid cells that is currently in remission with no detectable cancer cells.

Coding Tips

• •Remission status must be explicitly documented in clinical notes or pathology reports
• •This code indicates successful treatment response at the time of encounter

Clinical Significance

Acute myeloblastic leukemia in remission indicates successful response to induction chemotherapy with bone marrow recovery showing less than 5% blasts and normalized blood counts. Complete remission in AML is a critical milestone but does not equate to cure, as most patients require consolidation therapy to prevent relapse. Minimal residual disease (MRD) assessment increasingly guides post-remission treatment decisions.

Documentation Requirements

• ✓Provider must document complete remission with specific criteria: bone marrow blasts less than 5%, count recovery (neutrophils greater than 1.0, platelets greater than 100), and absence of Auer rods or extramedullary disease.
• ✓MRD status by flow cytometry or molecular methods should be documented when available.
• ✓Consolidation treatment plan, including consideration of allogeneic transplant based on risk stratification, must be recorded.

Commonly Confused Codes